Slone Epidemiology Center, Boston University, Boston, Massachusetts, USA.
Boston University School of Public Health, Boston, Massachusetts, USA.
J Clin Hypertens (Greenwich). 2023 Feb;25(2):168-174. doi: 10.1111/jch.14615. Epub 2023 Jan 6.
Evidence of an association between plasma 25-hydroxyvitamin D [25(OH)D] levels and risk of hypertension, predominantly from studies of White individuals, suggests an inverse relationship. Limited data are available on Black individuals, who are more likely to have vitamin D deficiency. In the Black Women's Health Study (BWHS), a prospective study of 59 000 self-identified Black women from across the US, we assessed levels of a validated predicted vitamin D score in relation to incident hypertension. We followed 42 239 participants who were free of cardiovascular disease and cancer from 1995 to 2019, during which time 19 505 incident cases of hypertension were identified. Cox proportional hazards model were used to calculate multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for the association of predicted vitamin D with the risk of incident hypertension. In age-adjusted analyses, there was a strong inverse dose-response association between predicted vitamin D score and hypertension risk, with an HR of .66 (95% CI: .63-.68, p trend < .0001) for the highest quartile of predicted vitamin D relative to the lowest. After control for potential confounders including body mass index, physical activity, and cigarette smoking, the HR was attenuated to .91 (95% CI: .87-.95, p trend = .002). In this prospective cohort study of Black women, predicted vitamin D score was weakly inversely associated with the incidence of hypertension. This observed association may reflect an inability to fully control for confounding factors.
有证据表明,血浆 25-羟维生素 D [25(OH)D] 水平与高血压风险之间存在关联,主要来自白种人群体的研究,表明两者呈负相关。关于黑人群体的数据有限,他们更有可能缺乏维生素 D。在黑人女性健康研究(BWHS)中,这是一项针对美国各地 59000 名自我认定的黑人女性的前瞻性研究,我们评估了经过验证的预测维生素 D 评分与高血压发病风险之间的关系。我们对 42239 名无心血管疾病和癌症的参与者进行了随访,从 1995 年到 2019 年,在此期间,有 19505 例高血压发病。我们使用 Cox 比例风险模型计算了预测维生素 D 与高血压发病风险之间的多变量调整后的风险比(HR)和 95%置信区间(CI)。在年龄调整分析中,预测维生素 D 评分与高血压风险之间存在很强的负剂量反应关系,与最低四分位数相比,预测维生素 D 评分最高四分位数的 HR 为.66(95%CI:.63-.68,p 趋势<.0001)。在控制了包括体重指数、身体活动和吸烟在内的潜在混杂因素后,HR 减弱至.91(95%CI:.87-.95,p 趋势=.002)。在这项针对黑人女性的前瞻性队列研究中,预测维生素 D 评分与高血压发病率呈弱负相关。这种观察到的关联可能反映出无法充分控制混杂因素。